Priveterra Acquisition priced its IPO of 24 million units at $10 per unit. The upsize represents a 20 percent increase from the 20 million units the SPAC initially planned to offer.
Units begin trading today on the Nasdaq under PMGMU. Each unit consists of one share of Class A common stock and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50.
Once the securities comprising the units begin separate trading, stock and warrants are expected to list on the Nasdaq under PMGM and PMGMW, respectively.
Priveterra intends to focus on the healthcare industry, particularly the medical technology sector. Read more.
